|
CERE
|
Cerevel Therapeutics Holdings, Inc.
|
2.90%
|
US
|
NASDAQ
|
|
ZLAB
|
Zai Lab Limited
|
2.73%
|
US
|
NASDAQ
|
|
ALKS
|
Alkermes plc
|
2.69%
|
US
|
NASDAQ
|
|
RXDX
|
Prometheus Biosciences, Inc.
|
2.68%
|
US
|
NASDAQ
|
|
CYTK
|
Cytokinetics, Incorporated
|
2.46%
|
US
|
NASDAQ
|
|
ARWR
|
Arrowhead Research Corporation
|
2.39%
|
US
|
NASDAQ
|
|
DNLI
|
Denali Therapeutics Inc.
|
2.37%
|
US
|
NASDAQ
|
|
PCVX
|
Vaxcyte, Inc.
|
2.22%
|
US
|
NASDAQ
|
|
VIR
|
Vir Biotechnology, Inc.
|
2.09%
|
US
|
NASDAQ
|
|
RARE
|
Ultragenyx Pharmaceutical Inc.
|
1.97%
|
US
|
NASDAQ
|
|
AXSM
|
Axsome Therapeutics, Inc.
|
1.78%
|
US
|
NASDAQ
|
|
GLPG
|
Galapagos NV
|
1.75%
|
US
|
NASDAQ
|
|
BPMC
|
Blueprint Medicines Corporation
|
1.69%
|
US
|
NASDAQ
|
|
ACAD
|
ACADIA Pharmaceuticals Inc.
|
1.69%
|
US
|
NASDAQ
|
|
ISEE
|
IVERIC bio, Inc.
|
1.60%
|
US
|
NASDAQ
|
|
PRTA
|
Prothena Corporation plc
|
1.57%
|
US
|
NASDAQ
|
|
MRTX
|
Mirati Therapeutics, Inc.
|
1.55%
|
US
|
NASDAQ
|
|
IMVT
|
Immunovant, Inc.
|
1.54%
|
US
|
NASDAQ
|
|
IMCR
|
Immunocore Holdings plc
|
1.49%
|
US
|
NASDAQ
|
|
AMLX
|
Amylyx Pharmaceuticals, Inc.
|
1.48%
|
US
|
NASDAQ
|